Beijing Huafeng Lianbo Technology Co., Ltd
Beijing Huafeng Lianbo, established in 2005, develops active pharmaceutical ingredients, focusing on compounds like Paclitaxel and Doxorubicin.
Introduction
Beijing Huafeng Lianbo Technology Co., Ltd., founded in 2005, is a technology-driven company dedicated to the production of active pharmaceutical ingredients and intermediates. With a robust focus on innovation, the company excels in new product development and conducts specialized research on compounds such as Paclitaxel, Doxorubicin Hydrochloride, Docetaxel, Epirubicin, and Doxorubicin.
Information
Categories
More Websites
Beta Pharma, Inc. develops accessible anticancer therapies to enhance patients' lives globally.INEOS Bio develops and licenses technology for renewable biofuels and power from various low-cost carbon materials.